Long-term outcome of patients with asystole induced by head-up tilt test

European Heart Journal

Volumn 23, Issue 6, 2002, Pages 483-489

  Barón Esquivias, Gonzalo ^a,d   Pedrote, A ^a   Cayuela, A ^a   Valle, J I ^a   Fernandez J M ^a   Arana, E ^a   Fernandez M ^a   Morales, F ^b   Burgos, J ^a   Martinez Rubio A ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d NONE   (Spain)

Author keywords

Asystole; Syncope; Tilt test; Treatment

Indexed keywords

ETILEFRINE; METOPROLOL;

ADULT; ARTICLE; ASYSTOLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PACEMAKER; PRIORITY JOURNAL; RECURRENT DISEASE; SPAIN; SYNCOPE; TILT TABLE TEST; TIME;

ADULT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; HEART ARREST; HUMANS; MALE; PACEMAKER, ARTIFICIAL; RECURRENCE; STATISTICS, NONPARAMETRIC; SYNCOPE; TILT-TABLE TEST;

EID: 0036522085     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2900     Document Type: Article

References (48)

1. Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt a useful test for investigating unexplained syncope. Lancet 1986; 1: 1325-54.
2. Fitzpatrick A, Theodorakis G, Vardas P et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J 1991; 12: 389-94.
3. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt induced vasovagal syncope. Eur J Card Pacing Electrophysiol 1992; 3: 180-3.
4. Benditt DG. Neurally mediated syncopal syndromes: Pathophysiological concepts and clinical evaluation. PACE 1997; 20: 572-84.
5. Milstein S, Buetinofer J, Lesser J et al. Cardiac asystole: A manifestation of neurally mediated hypotension-bradycardia. J Am Coll Cardiol 1989; 14: 1.626-1.632.
6. Maloney J, Jaeger F, Fouad-Tarazi F, Morris H. Malignant vasovagal syndrome: Prolonged asystole provoked by head up tilt. Cleve Clin J Med 1988; 55: 542-8.
7. Pedrote A, Errazquin J, Quero J, Sobrino M, Hernández MC. Prolonged cardiac asystole that requires resuscitation manoeuvers during a Head-up tilt table test. Rev Esp Cardiol 1993; 46: 313-5.
8. Barón-Esquivias G, Pedrote-Martínez A, Errázquin-Saez de Tejada F. Anomalous result and worsening of vasovagal syncope after a therapeutic regime with metoprolol guided by head-up tilt test. Eur J Card Pacing Electrophysiol 1996; 6: 60-1.
9. Dhala A, Natale A, Sra J et al. Relevance of asystole during Head-up tilt testing. Am J Cardiol 1995; 75: 251-4.
10. Folino AF, Buja GF, Martini B, Miorelli M, Nava A. Prolonged cardiac arrest and complete AV block during upright tilt test in young patients with syncope of unknown origin-prognostic and therapeutic implications. Eur Heart J 1992; 13: 1416-21.
11. Barón G, Pedrote A, Cardenal R, Pérez Cano B, L-Haldón J, Errazquin F. Estudio y tratamiento de la asistolia desarrollada durante el test de la tabla basculante (Abstr). Rev Esp Cardiol 1998; 51 (Suppl 5): 65.
12. Menozzi C, Brignole M, Lolli G et al. Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker. Am J Cardiol 1995; 72: 1152-5.
13. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R, Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17: 125-30.
14. Almquist A, Goldberg IF, Milstein S, Chen MY, Chen XC, Hansen R. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989; 320: 346-51.
15. Gregoratos G, Ceitlin MD, Conill A et al. ACC/AHA Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary. Circulation 1998; 97:1325-35.
16. Fitzpatrick A, Sutton R. Tilting towards a diagnosis in unexplained recurrent syncope. Lancet 1989; 1: 658-60.
17. Petersen ME, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994; 71: 274-81.
18. Sra JB, Jazayeri MR, Avitall B et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993; 328: 1085-90.
19. Grubb BP, Temesy-Armos P, Moore J, Wolfe D, Hahn H, Elliot L. Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome. Am J Cardiol 1992; 69: 904-8.
20. Brignole M, Menozzi C, Gianfranchi L, Bottoni N, Lolli G. The clinical and prognostic significance of the asystolic response during the head-up tilt test. Eur J Cardiovasc Pacing Electrophysiol 1992; 2: 109-13.
21. Deal BJ, Strieper M, Scagliotti D et al. The medical therapy of cardioinhibitory syncope in pediatric patients. PACE 1997;: 20:1759-61.
22. Pérez-Paredes M, Picó F, Sánchez JG et al. Prognosis and long-term follow-up in patients with syncope of unknown origin and cardiac asystole induced by head-up tilt test. Rev Esp Cardiol 1997; 50: 314-9.
23. Barón-Esquivias G, Pedrote A, Cayuela A et al. Age and gender differences in basal and isoprenaline protocols for head-up tilt table testing. Europace 2001; 3: 136-40.
24. Benditt DG, Ferguson DW, Grubb BP et al. Tilt table testing for assessing syncope. American College of cardiology. J Am Coll Cardiol 1996; 28: 263-75.
25. Petersen ME, Price D, Williams T, Jensen N, Rift K, Sutton R. Short AV interval VDD pacing does not prevent tilt induced vasovagal syncope in patients with cardioinhibitory vasovagal syndrome. PACE 1994; 17: 882-91.
26. el-Bedawi JCM, Wahbha MA, Hainsworth R. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope. Clin Auton Res 1994; 4: 233-7.
27. Benditt DG. Cardiac pacing for prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 21-3.
28. Benditt DG, Petersen M, Lurie KG, Grubb BP, Sutton R. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med 1995; 122: 204-9.
29. Sheldon R. Pacing to prevent vasovagal syncope. Cardiol Clin 2000; 18: 81-93.
30. Sra JS, Jazayeri MR, Dhala A, Deshpande S, Blanck Z, Akhtar M. Neurocardiogenic syncope, diagnosis, mechanisms, and treatment. Cardiol Clin 1993; 11: 183-91.
31. Fitzpatrick A, Theodorakis G, Ahmed R, Williams T, Sutton R. Dual chamber pacing aborts vasovagal syncope induced by head-up 60: Tilt. PACE 1991; 14: 13-9.
32. Moya A, Permanyer G, Sagrista J, Mont L, Rius T, Soler J. Response to dual chamber pacing patients with syncope and positive tilt test with cardioinhibitory response (Abstr). PACE 1993; 16: 936.
33. Samoil D, Grubb BP, Brewster P. Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope. Eur J Cardiovasc Pacing Electrophysiol 1993; 1: 36-41.
34. Maloney JD, Jaeger FJ, Rizo-Patron C, Zhu DW. The role of pacing for the management of neurally mediated syncope: Carotid sinus syndrome and vasovagal syncope. Am Heart J 1994; 127: 1030-7.
35. Kosinski D, Grubb BP, Elliot L, Dubois B. Treatment of malignant neurocardiogenic syncope with dual chamber cardiac pacing and fluoxetine hydrochloride. PACE 1995; 18: 1455-7.
36. Lacroix D, Koukam C, Plug D et al. Asystolic cardiac arrest during head-up tilt test: Incidence and therapeutic Implications. PACE 1997; 20: 2746-54.
37. Benditt DG, Sutton R, Gamage M and the rate-drop response investigators: Clinical experience with Thera-DR rate drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. PACE 1997; 20: 832-9.
38. Grubb BP. Permanent cardiac pacing: New and emerging indications other than cardiomyopathies. In: Barold S, Mugica J, ed. Recent advances in cardiac pacing: Goals for the 21st Century, Vol 4. Armonk, NY: Futura Publishing Co., 1998:89-99.
39. Sheldon R, Koshman ML, Wilson W, Kieser T, Rose S. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 1998; 81: 158-62.
40. Abe H, Iwami Y, Nagatomo T, Miura Y, Nakashima Y. Treatment of malignant neurocardiogenic vasovagal syncope with a rate drop algorithm in dual chamber cardiac pacing. PACE 1998; 21: 1473-5.
41. McLeod KA, Wilson N, Hewitt J, Norrie J, Stephenson JBP. Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures. Heart 1999; 82: 721-5.
42. Shah CP, Thakur RJ, Xie B, Pathak P. Dual chamber pacing for neurally mediated syncope with a prominent cardioinhibitory component. PACE 1999; 22: 999-1003.
43. Mitton CR, Rose MS, Koshman ML, Sheldon RS. Costutility analysis of pacemakers for the treatment of vasovagal syncope. Am J Cardiol 1999; 84: 1356-9.
44. Di Girolamo E, Di-Torio C, Leonzio L et al. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study. Circulation 1999; 100: 1798-1801.
45. Raviele A, Brignole M, Sutton R et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope. A double-blind randomized placebo-controlled trial. Circulation 1999; 99: 1452-7.
46. Madrid AH, Ortega J, Rebollo JG et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope, in a highly symptomatic population. A prospective, double blind, randomized and placebo controlled study. J Am Coll Cardiol 2001; 37: 554-9.
47. Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal pacemaker study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 16-20.
48. Sutton R, Brignole M, Menozzi C et al., for the Vasovagal Syncope International Study (VASIS) Investigators. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: A multicenter randomized study. Circulation 2000; 102: 294-9.